- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Merck & Co. Inc. (MRK)
Index:
- Change Today: $-1.47
- 52 Week High: $125.14
- 52 Week Low: $73.47
- Currency: US Dollars
- Shares Issued: 2,527.64m
- Volume: 614
- Market Cap: $309,534m
- RiskGrade: 92
Latest ShareCast News
Merck & Co to spin off cancer unit ahead of Keytruda patent cliff
By Benjamin Chiou
Date: Monday 23 Feb 2026
(Sharecast News) - US pharma group Merck & Co is set to spin off its oncology operations in an effort to keep its wider healthcare businesses immune from a forthcoming patent cliff for its blockbuster Keytruda drug.
Merck ShareCast News
Merck Newspaper Links
Merck Tips & Analysis
Merck News Wires
No recent information was found.
Merck Market Data
| Currency | US Dollars |
| Share Price | $ 122.46 |
| Change Today | $ -1.47 |
| % Change | -1.19 % |
| 52 Week High | $125.14 |
| 52 Week Low | $73.47 |
| Volume | 614 |
| Shares Issued | 2,527.64m |
| Market Cap | $309,534m |
| RiskGrade | 92 |
What The Brokers Say
| Strong Buy | 8 |
| Buy | 10 |
| Neutral | 10 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 28 |
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
You are here: research
Digital Look Ltd,
10 Lower Thames St,
London EC3R 6EN
10 Lower Thames St,
London EC3R 6EN